These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34847503)

  • 21. Operational and contextual barriers to accessing supervised consumption services in two Canadian cities.
    Urbanik MM; Greene C
    Int J Drug Policy; 2021 Feb; 88():102991. PubMed ID: 33166847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
    Park JN; Sherman SG; Rouhani S; Morales KB; McKenzie M; Allen ST; Marshall BDL; Green TC
    J Urban Health; 2019 Jun; 96(3):353-366. PubMed ID: 31168735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.
    Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T
    Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
    O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
    Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
    Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
    Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
    BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada.
    Scheim AI; Bouck Z; Tookey P; Hopkins S; Sniderman R; McLean E; Garber G; Baral S; Rourke SB; Werb D
    Int J Drug Policy; 2021 Jan; 87():102993. PubMed ID: 33160158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care.
    Quanbeck A; Brown RT; Zgierska AE; Jacobson N; Robinson JM; Johnson RA; Deyo BM; Madden L; Tuan WJ; Alagoz E
    Implement Sci; 2018 Jan; 13(1):21. PubMed ID: 29370813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Small communities, large oversight': The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada.
    Russell C; Imtiaz S; Ali F; Elton-Marshall T; Rehm J
    Int J Drug Policy; 2020 Aug; 82():102822. PubMed ID: 32563756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: Assessing the role of opioid overdose and injection behavior.
    Klein KS; Glick SN; Mauro PM
    Drug Alcohol Depend; 2020 Aug; 213():108121. PubMed ID: 32585421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supervised consumption sites: a nuanced assessment of the causal evidence.
    Caulkins JP; Pardo B; Kilmer B
    Addiction; 2019 Dec; 114(12):2109-2115. PubMed ID: 31309637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scoping review of harm reduction training for police officers.
    Khorasheh T; Naraine R; Watson TM; Wright A; Kallio N; Strike C
    Drug Alcohol Rev; 2019 Feb; 38(2):131-150. PubMed ID: 30785229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.